Global Multiplex Assays Market Report 2021: A Report Designed for Multiplex Assays Manufacturers, Vendors and Other Stakeholders

Dublin, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Multiplex Assays Market, By Product (Reagents & Consumables, Accessories & Instruments, Software & Services), By Type (Nucleic Acid, Protein, Cell-based), By Technology, By Application, By End User, By Region, forecast & opportunities, 2026" report has been added to's offering.

Global multiplex assays market is expected to undergo substantial rate of growth during the forecast period owing to technological advancements in healthcare sector, especially rapid development in nano technology.

Increasing prevalence of chronic diseases including cancer, where multiplex assays are significantly used, is also a major driving factor for the growth of this market. Additionally, various benefits of multiplex assays over singleplex and other traditional diagnostics is also anticipated to fuel the growth of multiplex market in the years to come.

Multiplex assay is a type of assay which measures multiple analytes in a single cycle. They are widely used in functional genomics to determine the effects of experimental treatments. A multiplex assay detects proteins and other biomolecules in a biological sample.

Global multiplex assays market can be segmented based on product, type, technology, application, end user and region. Based on technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The flow cytometry segment is expected to undergo significant growth during the forecast period as it works on the basis of bead population, which is helpful in computing specific antibody levels in biological fluids.

Region wise, North America is expected to dominate the global multiplex assays market by 2026 owing to regions' advanced healthcare system and availability of trained professionals. Various governments in the region are also supporting the development of advanced technologies for diagnostics, which is giving a major boost to multiplex assay companies.

Prominent market players are extensively undergoing research and development activities in order to introduce superior quality assays in the market.

Objective of the Study:

  • To analyze and forecast the market size of global multiplex assays market.
  • To forecast global multiplex assays market based on product, type, technology, application, end user, company and regional distribution.
  • To identify drivers and challenges for global multiplex assays market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global multiplex assays market.
  • To identify and analyze the profile of leading players operating in the global multiplex assays market.

Key Target Audience:

  • Multiplex assays manufacturers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to multiplex assays
  • Market research and consulting firms

Major companies operating in global multiplex assays market include

  • Abbott Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BUHLMANN Laboratories AG
  • Sekisui Medical Co., Ltd.
  • Randox Laboratories Ltd.

Report Scope:

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Global Multiplex Assays Market, By Product

  • Reagents & Consumables
  • Accessories & Instruments
  • Software & Services

Global Multiplex Assays Market, By Type

  • Nucleic Acid
  • Protein
  • Cell-based

Global Multiplex Assays Market, By Technology

  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Others

Global Multiplex Assays Market, By Application

  • Research & Development
  • Drug Development
  • Biomarker Discovery & Validation
  • Clinical Diagnosis
  • Infectious Disease
  • Cancer
  • Cardiovascular Disease
  • Autoimmune Disease
  • Nervous System Disorders
  • Others

Global Multiplex Assays Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Others

Global Multiplex Assays Market, By Region

  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

For more information about this report visit


Contact Data